The Journal of Urology
Volume 175, Issue 4 , Page 1364, April 2006

Serum Testosterone and the Risk of Prostate Cancer: Potential Implications for Testosterone Therapy

James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health and National Institute of Aging Intramural Research Program, Harbor Hospital, Baltimore, Maryland

Cancer Epidemiol Biomarkers Prev, 14: 2257–2260, 2005

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-5347(05)00880-3

doi:10.1016/S0022-5347(05)00880-3

The Journal of Urology
Volume 175, Issue 4 , Page 1364, April 2006

Article Tools